CIK 0001984086
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Septerna, Inc.
Sign in to watch- Ticker
- SEPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843891440
- Phone
- +1 650-338-3533
- Business address
- 250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion SVP, Biological Sciences acquired 23,008 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion CEO and President acquired 55,000 shares (option exercise)
- 4 Open-market buy Director bought 13,319 shares at $6.93 ($92,270)
- 4 Open-market buy Director bought 86,681 shares at an average $5.95 ($515,934)
- 4 Open-market buy CEO and President bought 17,000 shares at an average $5.70 ($96,961)
Page 3 of 5 · 83 filings